[ad_1] AstraZeneca PLC on Monday said its cancer drug Enhertu has shown clinically meaningful and…
Research/Development
-
-
STOCK MARKET
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns
by userby user[ad_1] Drug companies planning to raise prices on cancer drugs and other life-saving treatments are…
-
[ad_1] AbbVie Inc. executives lowered their outlook for the quarter and year in a filing…
-
STOCK MARKET
The top 1% was the only group to see real wage gains from 2020 to 2021, report says
by userby user[ad_1] Inequality in the U.S. deepened in 2021, with the country’s top 0.1% experiencing a…
-
[ad_1] Novartis AG said Monday that a trial to evaluate prostate-cancer drug Pluvicto met its…
-
STOCK MARKET
GSK Phase 3 trial for Jemperli endometrial cancer treatment met primary endpoint
by userby user[ad_1] GSK PLC said Friday that a Phase 3 trial for its Jemperli treatment for…
-
STOCK MARKET
5 things to know about the new Alzheimer’s drug — including why it may be risky for people who take blood thinners
by userby user[ad_1] Shares of Eisai and Biogen did not move dramatically after the drug companies reported…
-
STOCK MARKET
A new Alzheimer’s treatment may help some patients, though researchers say more safety data is needed
by userby user[ad_1] A new study found that Eisai and Biogen’s experimental Alzheimer’s drug moderately reduced cognitive…
-
[ad_1] Eisai 4523, +1.23% plans to share additional data about the Alzheimer’s disease treatment it’s…
-
[ad_1] While companies are lobbying Congress to bring back immediate tax deductions for research-and-development costs,…